Results 101 to 110 of about 3,844 (179)

Viro 100: Viro Pohjoismaana

, 2020
openaire   +1 more source

Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies. [PDF]

Mol Ther Oncol
Mooney R, Ngai G, Kaur G, Kang EY, Lara J, Abd El-Fattah EE, Huang P, Flores L, McDonald M, Talley M, Hammad M, Laidlaw M, Alamillo A, Nguyen DH, Lesniak MS, Curiel DT, Kortylewski M, Santidrian AF, Dellinger T, Aboody KS.   +19 more
europepmc   +1 more source

Screening drugs of Anemoside B4 for MFAP4 expression in osteosarcoma in PDTX to increase personalized medicine. [PDF]

Discov Oncol
Zhang L, Zeng L, Zhang J, He Z, Liu X.
europepmc   +1 more source

Viro tärkeä yhteistyökumppani

, 2020
Viljamaa Anmari, Lauhanen Risto
openaire   +1 more source

Ultra-Sensitive Aptamer-Based Diagnostic Systems for Rapid Detection of All SARS-CoV-2 Variants. [PDF]

Int J Mol Sci
Kim SW, Han MJ, Rahman MS, Kim H, Noh JE, Lee MK, Kim M, Lee JO, Jang SK.   +8 more
europepmc   +1 more source

Report on VIRO-FLOW Schools

Description of VIROFLOW Schools and actions ...
openaire   +1 more source

Retraction Note: An overview on mRNA-based vaccines to prevent monkeypox infection. [PDF]

J Nanobiotechnology
Natami M, Gorgzadeh A, Gholipour A, Fatemi SN, Firouzeh N, Zokaei M, Mohammed Ali SH, Kheradjoo H, Sedighi S, Gholizadeh O, Kalavi S.   +10 more
europepmc   +1 more source

The Effect of SARS-CoV-2 Vaccination on HIV Viral Load in Patients Under Bictegravir/Tenofovir Alafenamide/Emtricitabine Therapy: A Retrospective Observational Study. [PDF]

Healthcare (Basel)
Pipitone G, Ciusa G, Agrenzano S, Di Lorenzo F, Sagnelli C, Cascio A, Iaria C, TheBICivico StudyGroup.   +7 more
europepmc   +1 more source

Atorvastatin and telmisartan do not reduce nasopharyngeal carriage of SARS-CoV-2 in mild or moderate COVID-19 in a phase IIb randomized controlled trial. [PDF]

Sci Rep
Bonnet F, Doumbia A, Machault V, Ello FN, Bellecave P, Akpovo CB, Sidibe BT, Fernandez L, Kouamé A, Adjogoua E, Dosso M, Niangoran S, Journot V, Eholié SP.   +13 more
europepmc   +1 more source